AINSLEYSHEA'S Newsroom : RushPRNews - Newswire & Global Press Release Distribution

 

Wendy F. Hensel, Associate Dean and Professor of Law at Georgia State University, Joins ASTEP Board of Directors

NEW YORK, NY (RPRN) 02/11/15 — By AinsleyShea
-ASTEP, a leader in promoting the inclusion of individuals with Asperger Syndrome and similar autism spectrum profiles in competitive employment, is proud to announce the addition of Wendy F. Hensel,...

Dr. Ken Pool, IT Pioneer, dead at 62, leaves a rich legacy in health data standards and public health

ARLINGTON, TX (RPRN) 01/17/15 — By AinsleyShea
With deep sadness  OZ Systems announces the sudden passing of health IT pioneer Dr. Ken Pool, the company’s co-founder, Chairman and Chief Operating Officer. Dr. Pool died on January 12th at the...

Dr. Ken Pool, Founder and Chairman of Dallas-based OZ Systems, Dies at 62

ARLINGTON, TX (RPRN) 01/16/15 — By AinsleyShea
It is with deep sadness that OZ Systems announces the unexpected passing of health IT pioneer Dr. Ken Pool, the company’s co-founder, Chairman and Chief Operating Officer. Dr. Pool died on...

OZ Systems Partners with JPS Health Network to Implement Newborn Screening IT System

ARLINGTON, TX (RPRN) 12/30/14 — By AinsleyShea
New Platform Supports Recently Added Screening, Builds on Initiatives to Enhance Newborn Care, Reduces Infant Mortality OZ Systems, a leading provider of public health information systems, has partnered with JPS Health Network...

GeneSegues Therapeutics Awarded Contract For Development of Nanocapsule-based Vaccine for Biodefense Pathogen

MINNEAPOLIS, MN (RPRN) 12/18/14 — By AinsleyShea
Company Collaborating With U.S. Army Researchers on Topically Applied DNA Vaccine  GeneSegues Therapeutics, a leader in the targeted delivery of RNAi and DNA therapeutics and vaccines in cancer and infectious disease,...

GeneSegues Awarded $1 Million Phase II NIH/NCI Research Contract for Nanoencapsulated RNAi Cancer Therapeutic

MINNEAPOLIS, MN (RPRN) 11/10/14 — By AinsleyShea
Highly Competitive NIH Program Validates Potential of GS-10 for Solid Tumor Cancers GeneSegues Therapeutics, a leader in the targeted delivery of RNAi and DNA therapeutics in cancer and infectious disease, announced...

Cancer Drug Developer GeneSegues Therapeutics Names Laura Morris Brod as CEO

MINNEAPOLIS, MN (RPRN) 10/29/14 — By AinsleyShea
Company Positioned to Accelerate Growth Plans GeneSegues Therapeutics, a leader in innovative RNAi and DNA therapeutics for cancer and infectious diseases, today announced the addition of its new CEO. “We’re very excited...

Newborn Health & Technology Leader Dr. Terese Finitzo Receives ‘Eve Award’ for Innovation

MINNEAPOLIS, MN (RPRN) 10/10/14 — By AinsleyShea
Newborn Foundation Awards Gala honors global leaders in technology, public health and medicine Dr. Terese Finitzo, clinical pediatric audiologist and CEO of OZ Systems, receives the Eve Award for Innovation in...

OZ Systems Partners with Largest Physician-Owned Hospital in US to Implement Newborn Screening IT System

MCALLEN, TX (RPRN) 10/01/14 — By AinsleyShea
New Platform Aims to Improve Workflow and Interoperability While Enhancing Newborn Safety OZ Systems, a leading provider of public health information systems, has partnered with Doctors Hospital at Renaissance (DHR) and...

The Newborn Foundation and Newborn Coalition Applaud Pennsylvania and Wisconsin for Advancements in Newborn Screening

Saint Paul, MN (RPRN) 07/07/14 — By AinsleyShea
The Newborn Foundation and Newborn Coalition applaud the states of Pennsylvania and Wisconsin for their recent enactment of legislation and provisions to add newborn heart screening to the uniform panel...

Are you a reporter or an editor looking to join our highly targeted media lists?


Subscribe To Our Mailing Lists